Effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA Vaccination in Preventing COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Nonimmunocompromised Children and Adolescents Aged 5–1 - cdc.gov

3/3/2022 12:00:00 AM3 years 1 month ago
by CDC
by CDC
This report describes mRNA COVID-19 vaccine effectiveness in ..
On March 1, 2022, this report was posted online as an MMWR Early Release. Nicola P. Klein, MD1; Melissa S. Stockwell, MD2,3,4; Maria Demarco, PhD5; Manjusha Gaglani, MBBS6,7; Anupam B. Kharbanda, MD… [+53369 chars]
full article...